Buyer for prescription drug CDMO in Europe

Company to buy

• Size: Mid-size business
• Revenue: 3-30 M EUR
• Location of the target company: Europe
• CFIE PHB287

Overview of buyer for prescription drugs CDMO in Europe

A prominent US-headquartered Contract Development and Manufacturing Organization (CDMO) has been serving the pharmaceutical, biotech, generic, and CDMO sectors since two decades. The company is recognized globally for its expertise in providing end-to-end solutions that encompass regulatory starting materials (RSMs), intermediates, Active Pharmaceutical Ingredients (APIs), highly potent APIs, sterile APIs, and sterile drug product formulations. With a steadfast commitment to quality, innovation, and compliance, it has emerged as a trusted partner for clients worldwide.

Profile of buyer for prescription drugs CDMO in Europe

The organization operates US-FDA-inspected, GMP-compliant manufacturing facilities equipped with cutting-edge sterile suspension injectable manufacturing capabilities. Its dedicated drug product formulation research and development laboratory enhances its proficiency in delivering innovative solutions, particularly for complex injectables. Boasting a workforce of approximately 500 skilled professionals, the company emphasizes sustainable practices, adhering to industry-leading principles to ensure environmentally friendly operations.

Activity and Products of buyer for prescription drugs CDMO in Europe

The company offers a comprehensive suite of services designed to support the entire drug development and commercialization lifecycle. Its core expertise lies in formulation and analytical development for complex drug products, cGMP commercial manufacturing, and API process and analytical development. The organization also specializes in sterile API and excipient manufacturing, along with cGMP production of sterile injectable suspensions and sterile powder fills. Also with a strong focus on addressing challenges posed by poorly soluble and highly potent compounds, it excels in delivering solutions for both sterile and non-sterile environments. This extensive range of capabilities positions the company as a trusted partner for innovative and generic sectors alike.

Highlights of buyer for prescription drugs CDMO in Europe

• The company has a proven track record of delivering cGMP manufacturing solutions for development and commercial stages, catering to clients in North America and Europe.
• It has successfully passed US FDA inspections multiple times, reinforcing its commitment to the highest regulatory standards.
• With a robust infrastructure and a team of industry experts, the organization specializes in complex drug product formulation development, drug implant development, and a variety of supporting services, including analytical and physical characterization.
• It is dedicated to fostering ethical business practices, environmental stewardship, and quality excellence in all aspects of its operations.

More information on this buyer for prescription drug CDMO in Europe

Please get in touch if you are interested in learning more about this buyer for prescription drug CDMO in Europe. For more cmo companies for sale please visit the section cmo companies for sale. For other cmo buyers, please visit the section cmo companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.